Penserra Capital Management LLC Biocryst Pharmaceuticals Inc Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 15, 2022	SELL	$11.18 - $15.46 $45,838 - $63,386	-4,100 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$14.21 - $17.65 $781 - $970	55 Added 1.36%	4,100 $58,000
Q2 2021 Aug 12, 2021	BUY	$9.5 - $17.24 $427 - $775	45 Added 1.13%	4,045 $63,000
Q1 2021 May 13, 2021	SELL	$7.37 - $13.61 $884 - $1,633	-120 Reduced 2.91%	4,000 $40,000
Q4 2020 Feb 12, 2021	BUY	$3.37 - $8.61 $8,809 - $22,506	2,614 Added 173.57%	4,120 $30,000
Q3 2020 Nov 13, 2020	BUY	$3.43 - $5.53 $5,165 - $8,328	1,506 New	1,506 $5,000

260

173M

397K

444K

Ticker BCRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,944,992
Market Cap $1.43B
Description
BioCryst Pharmaceuticals, Inc., a biotechnology company, discovers novel, oral, and small-molecule medicines. The company markets peramivir injection, an intravenous neuraminidase inhibitor for the treatment of acute uncomplicated influenza under the RAPIVAB, RAPIACTA, and PERAMIFLU names; and ORLADEYO, an oral serine protease inhibitor to treat...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.